Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival

被引:10
|
作者
Wohnrath, Durval R. [1 ]
Araujo, Raphael L. C. [1 ,2 ,3 ,4 ]
机构
[1] Barretos Canc Hosp, Dept Upper Gastrointestinal & Hepato Pancreto Bil, Barretos, SP, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Digest Surg, Rua Botucatu 740, BR-04023062 Sao Paulo, SP, Brazil
[3] United Hlth Grp, Amer Med Serv Brazil, Dept Oncol, Sao Paulo, SP, Brazil
[4] Hosp Israelita Albert Einstein, Dept Oncol, Sao Paulo, SP, Brazil
关键词
gastric cancer; lymphadenectomy; oncologic outcomes; surgery; survival; EXAMINED LYMPH-NODES; PARAAORTIC LYMPHADENECTOMY; SELECTING PATIENTS; N-RATIO; DISSECTION; D2; CHEMORADIOTHERAPY; ADENOCARCINOMA; SUPERIORITY; SURGERY;
D O I
10.1002/jso.25755
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionThis study addressed whether the positive node-ratio (N-ratio) for patients who underwent curative-intent treatment was an independent prognostic factor of overall survival (OS) for gastric adenocarcinoma (GA). MethodsConsecutive patients who underwent gastrectomy for GA with at least 15 harvested nodes were evaluated for 5-year OS. The best threshold was determined using the area under an receiver operating characteristic (ROC) curve. Univariate and multivariate models were assessed looking for independent prognostic factors for OS. ResultsFrom 1994 to 2015, 398 consecutive patients were evaluated. The N-ratio >= 11% had an accuracy of 0.764, the sensitivity of 71.1%, the specificity of 81.7%, positive predictive value (PPV) of 91.7%, and odds ratio (OR) of 11. After multivariate analysis for OS, age >= 70 years (HR 1.44), need for total gastrectomy (HR 1.45), need for extended resection (HR 1.7), and N-ratio >= 11% (HR 3.7) were unfavorable prognostic factors. D2 lymphadenectomy (HR 0.53) was a protective factor. The median OS according to N-ratio was 14 months for N-ratio >11 vs 58 months for N-ratio <11%. ConclusionThe N-ratio >= 11% was an independent negative prognostic factor for patients who underwent treatment for GA with curative intent. The N-ratio >= 11% presented high specificity, high PPV and high OR for risk of death for 5 years after surgery.
引用
收藏
页码:777 / 783
页数:7
相关论文
共 50 条
  • [31] Lymph node ratio as an independent prognostic factor for breast cancer-related mortality in patients with node-positive breast cancer
    Cetin, Ilknur Alsan
    Akay, Sitki Utku
    Ozkok, Hale Basak Caglar
    Sengoz, Meric
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (06) : 1387 - 1392
  • [32] The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality
    Solak, Mustafa
    Turkoz, Fatma P.
    Keskin, Ozge
    Aksoy, Sercan
    Babacan, Taner
    Sarici, Furkan
    Kertmen, Neyran
    Sever, Ali R.
    Altundag, Kadri
    JOURNAL OF BUON, 2015, 20 (03): : 737 - 745
  • [33] Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment
    Aoyama, Toru
    Komori, Kesikeu
    Tamagawa, Ayako
    Nakazano, Masato
    Hara, Kentaro
    Hashimoto, Itaru
    Tamagawa, Hiroshi
    Segami, Kenki
    Maezawa, Yukio
    Kano, Kazuki
    Oshima, Takashi
    Yukawa, Norio
    Rino, Yasushi
    IN VIVO, 2022, 36 (02): : 994 - 1000
  • [34] Preoperative neutrophil-to-lymphocyte ratio behaves as an independent prognostic factor even in patients with postoperative complications after curative resection for gastric cancer
    Tur-Martinez, Jaume
    Osorio, Javier
    Perez-Romero, Noelia
    Puertolas-Rico, Noelia
    Pera, Manuel
    Delgado, Salvadora
    Rodriguez-Santiago, Joaquin
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (03) : 1017 - 1026
  • [35] The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
    Aoyama, Toru
    Ju, Miwa
    Komori, Keisuke
    Tamagawa, Hiroshi
    Tamagawa, Ayako
    Onodera, Atsushi
    Morita, Junya
    Hashimoto, Itaru
    Ishiguro, Tetsushi
    Endo, Kazuya
    Cho, Haruhiko
    Onuma, Shizune
    Fukuda, Momoko
    Oshima, Takashi
    Yukawa, Norio
    Rino, Yasushi
    IN VIVO, 2022, 36 (04): : 1916 - 1922
  • [36] Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent
    Liang, Yuexiang
    Wu, Liangliang
    Wang, Xiaona
    Ding, Xuewei
    Liu, Hongmin
    Li, Bin
    Wang, Baogui
    Pan, Yuan
    Zhang, Rupeng
    Liu, Ning
    Liang, Han
    CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (06) : 580 - 587
  • [37] The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery
    Aoyama, Toru
    Hashimoto, Itaru
    Maezawa, Yukio
    Hara, Kentaro
    Komori, Keisuke
    Otani, Kazuki
    Kazama, Keisuke
    Sawazaki, Sho
    Numata, Masakatsu
    Kamiya, Natsumi
    Kato, Aya
    Yamada, Takanobu
    Nagasawa, Shinsuke
    Kawahara, Shinnosuke
    Cho, Haruhiko
    Morita, Junya
    Tanabe, Mie
    Yukawa, Norio
    Saito, Aya
    Rino, Yasushi
    Ogata, Takashi
    Oshima, Takashi
    ANTICANCER RESEARCH, 2023, 43 (11) : 5181 - 5187
  • [38] Positive Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes
    Da-zhi Xu
    Qi-rong Geng
    Zi-jie Long
    You-qing Zhan
    Wei Li
    Zhi-wei Zhou
    Ying-bo Chen
    Xiao-wei Sun
    Gong Chen
    Quentin Liu
    Annals of Surgical Oncology, 2009, 16 : 319 - 326
  • [39] Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer
    Jankova, Lucy
    Dent, Owen F.
    Chan, Charles
    Chapuis, Pierre
    Clarke, Stephen J.
    BMC CANCER, 2013, 13
  • [40] Differences in the treatment of young gastric cancer patients: Patients under 50 years have better 5-year survival than older patients
    Schildberg, C. W.
    Croner, R.
    Schellerer, V
    Haupt, W.
    Schildberg, F. W.
    Schildberg, M.
    Hohenberger, W.
    Horbach, T.
    ADVANCES IN MEDICAL SCIENCES, 2012, 57 (02): : 259 - 265